Product Description
Mechanisms of Action: Ceruloplasmin Cofactor,Cytochrome C Oxidase Cofactor,LOX Cofactor,SOD Cofactor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: N/A
FDA Designation: None *
Approval Status: Approved
Approved Countries: Australia | Colombia | Malaysia | Taiwan | United Arab Emirates | Venezuela
Approved Indications: None
Known Adverse Events: None
Company: American Regent
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic: